Resultados de la búsqueda 201-210 de 3763 para anti-TNF drugs

  1. Clinical Update - July 2009 - MC2024-0709

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... anti-angiogenesis and chemotherapy in advanced ... Iobenguane I-131 or Crizotinib and Standard Therapy ... treatment surface as a surrogate for a conventional CT ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as daunorubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by ...

  8. Acidófilos - Mayo Clinic

    Natural Medicines. https://naturalmedicines.therapeuticresearch.com ... Lactobacillus acidophilus LB: A useful pharmabiotic for the treatment of digestive ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Eliminating Breast Cancer Surgery in Exceptional Responders with Neoadjuvant Systemic Therapy. Rochester, Minn. The goal of this clinical research study is to ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...